593 related articles for article (PubMed ID: 19139018)
1. Estrogen receptor-beta as a potential target for colon cancer prevention: chemoprevention of azoxymethane-induced colon carcinogenesis by raloxifene in F344 rats.
Janakiram NB; Steele VE; Rao CV
Cancer Prev Res (Phila); 2009 Jan; 2(1):52-9. PubMed ID: 19139018
[TBL] [Abstract][Full Text] [Related]
2. Chemoprevention of colon carcinogenesis by the natural product of a simple phenolic compound protocatechuic acid: suppressing effects on tumor development and biomarkers expression of colon tumorigenesis.
Tanaka T; Kojima T; Suzui M; Mori H
Cancer Res; 1993 Sep; 53(17):3908-13. PubMed ID: 8358716
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon.
Rao CV; Desai D; Simi B; Kulkarni N; Amin S; Reddy BS
Cancer Res; 1993 Sep; 53(18):4182-8. PubMed ID: 8364913
[TBL] [Abstract][Full Text] [Related]
4. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
5. Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer.
Singh J; Hamid R; Reddy BS
Cancer Res; 1997 Jan; 57(2):253-8. PubMed ID: 9000564
[TBL] [Abstract][Full Text] [Related]
6. Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats.
Kawamori T; Tanaka T; Hara A; Yamahara J; Mori H
Cancer Res; 1995 Mar; 55(6):1277-82. PubMed ID: 7882322
[TBL] [Abstract][Full Text] [Related]
7. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
[TBL] [Abstract][Full Text] [Related]
8. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids.
Rao CV; Hirose Y; Indranie C; Reddy BS
Cancer Res; 2001 Mar; 61(5):1927-33. PubMed ID: 11280748
[TBL] [Abstract][Full Text] [Related]
9. Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells.
Raju J; Patlolla JM; Swamy MV; Rao CV
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1392-8. PubMed ID: 15298963
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity.
Rao CV; Wang CQ; Simi B; Rodriguez JG; Cooma I; El-Bayoumy K; Reddy BS
Cancer Res; 2001 May; 61(9):3647-52. PubMed ID: 11325834
[TBL] [Abstract][Full Text] [Related]
11. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of colon carcinogenesis by the synthetic organoselenium compound 1,4-phenylenebis(methylene)selenocyanate.
Reddy BS; Rivenson A; Kulkarni N; Upadhyaya P; el-Bayoumy K
Cancer Res; 1992 Oct; 52(20):5635-40. PubMed ID: 1394188
[TBL] [Abstract][Full Text] [Related]
13. Catalpa seed oil rich in 9t,11t,13c-conjugated linolenic acid suppresses the development of colonic aberrant crypt foci induced by azoxymethane in rats.
Suzuki R; Yasui Y; Kohno H; Miyamoto S; Hosokawa M; Miyashita K; Tanaka T
Oncol Rep; 2006 Nov; 16(5):989-96. PubMed ID: 17016582
[TBL] [Abstract][Full Text] [Related]
14. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis.
Singh J; Hamid R; Reddy BS
Cancer Res; 1997 Aug; 57(16):3465-70. PubMed ID: 9270014
[TBL] [Abstract][Full Text] [Related]
15. Effect of amount and types of dietary fat on intestinal bacterial 7 alpha-dehydroxylase and phosphatidylinositol-specific phospholipase C and colonic mucosal diacylglycerol kinase and PKC activities during stages of colon tumor promotion.
Reddy BS; Simi B; Patel N; Aliaga C; Rao CV
Cancer Res; 1996 May; 56(10):2314-20. PubMed ID: 8625306
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of azoxymethane-induced colon carcinogenesis by dietary feeding of S-methyl methane thiosulfonate in male F344 rats.
Kawamori T; Tanaka T; Ohnishi M; Hirose Y; Nakamura Y; Satoh K; Hara A; Mori H
Cancer Res; 1995 Sep; 55(18):4053-8. PubMed ID: 7664279
[TBL] [Abstract][Full Text] [Related]
17. Preventive effect of fermented brown rice and rice bran against colon carcinogenesis in male F344 rats.
Katyama M; Yoshimi N; Yamada Y; Sakata K; Kuno T; Yoshida K; Qiao Z; Vihn PQ; Iwasaki T; Kobayashi H; Mori H
Oncol Rep; 2002; 9(4):817-22. PubMed ID: 12066215
[TBL] [Abstract][Full Text] [Related]
18. Decrease in size of azoxymethane induced colon carcinoma in F344 rats by 180-day fermented miso.
Ohuchi Y; Myojin Y; Shimamoto F; Kashimoto N; Kamiya K; Watanabe H
Oncol Rep; 2005 Dec; 14(6):1559-64. PubMed ID: 16273256
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
20. Preventive effects of extract of leaves of ginkgo (Ginkgo biloba) and its component bilobalide on azoxymethane-induced colonic aberrant crypt foci in rats.
Suzuki R; Kohno H; Sugie S; Sasaki K; Yoshimura T; Wada K; Tanaka T
Cancer Lett; 2004 Jul; 210(2):159-69. PubMed ID: 15183531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]